These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 21278391)

  • 1. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset.
    Smith MJ; Higgs JE; Bowers NL; Halliday D; Paterson J; Gillespie J; Huson SM; Freeman SR; Lloyd S; Rutherford SA; King AT; Wallace AJ; Ramsden RT; Evans DG
    J Med Genet; 2011 Apr; 48(4):261-5. PubMed ID: 21278391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further genotype--phenotype correlations in neurofibromatosis 2.
    Selvanathan SK; Shenton A; Ferner R; Wallace AJ; Huson SM; Ramsden RT; Evans DG
    Clin Genet; 2010 Feb; 77(2):163-70. PubMed ID: 19968670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
    Evans DG; Watson C; King A; Wallace AJ; Baser ME
    J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
    Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
    BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
    Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
    Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF2 status of meningiomas is associated with tumour localization and histology.
    Kros J; de Greve K; van Tilborg A; Hop W; Pieterman H; Avezaat C; Lekanne Dit Deprez R; Zwarthoff E
    J Pathol; 2001 Jul; 194(3):367-72. PubMed ID: 11439370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography.
    Kim JH; Kim IS; Kwon SY; Jang BC; Suh SI; Shin DH; Jeon CH; Son EI; Kim SP
    Int J Mol Med; 2006 Jul; 18(1):27-32. PubMed ID: 16786152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
    Ruttledge MH; Sarrazin J; Rangaratnam S; Phelan CM; Twist E; Merel P; Delattre O; Thomas G; Nordenskjöld M; Collins VP
    Nat Genet; 1994 Feb; 6(2):180-4. PubMed ID: 8162072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infratentorial meningioma in an 8-year-old child as first sign of neurofibromatosis type 2.
    Stettner GM; Rostasy KM; Ludwig HC; Merkler D; Fahsold R; Gärtner J
    Neuropediatrics; 2007 Feb; 38(1):29-31. PubMed ID: 17607601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
    Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
    Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients.
    Aboukais R; Baroncini M; Zairi F; Bonne NX; Schapira S; Vincent C; Lejeune JP
    Acta Neurochir (Wien); 2013 May; 155(5):771-7. PubMed ID: 23381342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phenotype-genotype study in 154 French NF2 mutation carriers].
    Demange L; De Moncuit C; Thomas G; Olschwang S
    Rev Neurol (Paris); 2007 Nov; 163(11):1031-8. PubMed ID: 18033041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.
    De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L
    Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 2: molecular and clinical analyses in Argentine sporadic and familial cases.
    Ferrer M; Schulze A; Gonzalez S; Ferreiro V; Ciavarelli P; Otero J; Giliberto F; Basso A; Szijan I
    Neurosci Lett; 2010 Aug; 480(1):49-54. PubMed ID: 20553997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants.
    Wellenreuther R; Waha A; Vogel Y; Lenartz D; Schramm J; Wiestler OD; von Deimling A
    Lab Invest; 1997 Dec; 77(6):601-6. PubMed ID: 9426397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.
    Abi Jaoude S; Peyre M; Degos V; Goutagny S; Parfait B; Kalamarides M
    J Neurosurg; 2021 May; 134(5):1377-1385. PubMed ID: 32442973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.
    Antinheimo J; Sankila R; Carpén O; Pukkala E; Sainio M; Jääskeläinen J
    Neurology; 2000 Jan; 54(1):71-6. PubMed ID: 10636128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonality of multiple meningiomas.
    Stangl AP; Wellenreuther R; Lenartz D; Kraus JA; Menon AG; Schramm J; Wiestler OD; von Deimling A
    J Neurosurg; 1997 May; 86(5):853-8. PubMed ID: 9126902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic variability associated with 14 splice-site mutations in the NF2 gene.
    Kluwe L; MacCollin M; Tatagiba M; Thomas S; Hazim W; Haase W; Mautner VF
    Am J Med Genet; 1998 May; 77(3):228-33. PubMed ID: 9605590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.